News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ChinaBio(R) LLC Release: China Announces New $3.2 Billion Drug Development Program



3/24/2014 8:55:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

March 21, 2014 -- China’s National Health and Family Planning Commission (NHFPC) will invest $3.2 billion in R&D projects for new drugs that target ten major diseases. The effort is to take place during the 12th Five-Year Plan, which ends in 2015, leaving less than two years to make the investments. The diseases include cancer, cardiovascular and cerebrovascular diseases, neurodegenerative disorder, mental disorders, diabetes, autoimmune disease, drug-resistant pathogen infection, tuberculosis and other common diseases. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES